Glycosylation in the endoplasmic reticulum (ER) is closely associated with protein folding and quality control. We recently described a non-canonical ER quality control mechanism for folding of thrombospondin type 1 repeats by protein O-fucosyltransferase 2 (POFUT2). Epidermal growth factor-like (EGF) repeats are also small cysteine-rich protein motifs that can be O-glycosylated by several ER-localized enzymes, including protein O-glucosyltransferase 1 (POGLUT1) and POFUT1. Both POGLUT1 and POFUT1 modify the Notch receptor on multiple EGF repeats and are essential for full Notch function. The fact that POGLUT1 and POFUT1 can distinguish between folded and unfolded EGF repeats raised the possibility that they participate in a quality control pathway for folding of EGF repeats in proteins such as Notch. Here, we demonstrate that cell-surface expression of endogenous Notch1 in HEK293T cells is dependent on the presence of POGLUT1 and POFUT1 in an additive manner. In vitro unfolding assays reveal that addition of O-glucose or O-fucose stabilizes a single EGF repeat and that addition of both O-glucose and O-fucose enhances stability in an additive manner. Finally, we solved the crystal structure of a single EGF repeat covalently modified by a full O-glucose trisaccharide at 2.2 Å resolution. The structure reveals that the glycan fills up a surface groove of the EGF with multiple contacts with the protein, providing a chemical basis for the stabilizing effects of the glycans. Taken together, this work suggests that O-fucose and O-glucose glycans cooperatively stabilize individual EGF repeats through intramolecular interactions, thereby regulating Notch trafficking in cells.
Glycosylation in the endoplasmic reticulum (ER) 4 has long been associated with protein folding (1, 2) . Oligosaccharyltransferase modifies newly synthesized proteins as they emerge in the lumen of the ER with N-glycans that are trimmed and recognized by calnexin/calreticulin chaperones, allowing a round of protein folding. Folded proteins move on, and unfolded proteins are recognized and re-glucosylated by the UDP-glucose glycoprotein glucosyltransferase (UGGT) to allow another folding cycle. In addition to this well-known pathway, we recently identified a non-canonical quality control pathway for folding of thrombospondin type 1 repeats (TSRs) (3) . TSRs are small protein motifs (ϳ60 amino acids) typically found as tandem repeats in proteins (4) . They are defined by six conserved cysteines forming three disulfide bonds. Most TSRs contain a consensus sequence for modification by protein O-fucosyltransferase 2 (POFUT2), a soluble enzyme in the ER lumen (5, 6) . POFUT2 only modifies folded TSRs (6) , and knockdown of POFUT2 in cells results in loss of secretion of multiple target proteins (3) . The addition of O-fucose appears to stabilize the folded form of a TSR, accelerating its folding and secretion (3) . Thus, in contrast to the classical N-glycan quality control pathway where UGGT recognizes an unfolded substrate, POFUT2 recognizes and modifies a folded structure.
Epidermal growth factor-like (EGF) repeats are also modified by O-glycans in the ER (7, 8) . Similar to TSRs, EGF repeats are small protein motifs (ϳ40 amino acids) found as tandem repeats, also defined by six cysteines forming three disulfide bonds (9) . Three O-glycans are added at specific sites on EGF repeats by three separate enzymes: protein O-glucosyltransferase 1 (POGLUT1) adds O-glucose to serine residues within the sequence C 1 XSX(P/A)C 2 (where C 1 and C 2 are the first and second conserved cysteine of the EGF repeat); POFUT1 adds O-fucose to serine/threonine residues within the sequence C 2 XXXX(S/T)C 3 ; and EGF-specific O-GlcNAc transferase (EOGT) adds O-GlcNAc to serine/threonine residues within the sequence C 5 XXGX(T/S)GXXC 6 (10, 11) . All three enzymes modify multiple EGF repeats in the extracellular domain of the Notch receptor (12) (13) (14) , and these modifications are essential for optimal Notch activity (15) (16) (17) . Human diseases result from inactivating mutations in these enzymes and appear to be mediated by reduced Notch function (17) (18) (19) (20) . O-Glucose can be elongated by xylosyltransferases (GXYLT1/2 and XXYLT1) to form the trisaccharide Xyl␣1-3Xyl␣1-3Glc, and O-fucose can be elongated by Fringe enzymes (LFNG, MFNG, and RFNG) to ultimately form the tetrasaccharide Sia␣2-6Gal␤1-4GlcNAc␤1-3Fuc (21) (22) (23) (24) . Elongation of O-fucose or O-glucose is known to modulate Notch activity (13, 25, 26) .
POGLUT1, POFUT1, and EOGT are all localized to the ER and only modify properly folded EGF repeats (7, 8, 27) , suggesting they may participate in a quality control pathway for the folding of EGF repeats similar to that of POFUT2 and TSRs. Nonetheless, the effects of eliminating these enzymes in model systems have shown a variety of effects on the trafficking of Notch to the cell surface, which seem to vary with cell type or system. Early studies in flies showed that the Drosophila form of POFUT1 (Ofut1) has chaperone activity that is independent of its fucosyltransferase activity and required for proper cell-surface expression of Notch (28) . In contrast, Notch receptors, although non-functional, are expressed on the cell surface of mouse embryonic stem cells that lack Pofut1 (29) . Other results in mice suggest loss of Pofut1 does result in Notch trafficking defects in certain cells (30) . Similarly, elimination of the Drosophila form of POGLUT1 (Rumi) caused some Notch trafficking defects, whereas knockdown of Poglut1 in mouse cell lines did not reduce cell-surface Notch (8, 16) . Elimination of EOGT in mammalian cells does not appear to have any effect on Notch trafficking (17) .
A recent study in flies suggested that POGLUT1 and POFUT1 cooperate in folding and trafficking of the Notch receptor (31) , raising the intriguing possibility that these enzymes may not function independently but work together, perhaps with additional cellular components, to fully fold the active Notch receptor. This would help to explain some of the variability seen in different systems described above. Here, we examine whether this is the case in mammalian cells. Using CRISPR/CAS9, we generated POGLUT1 and POFUT1 single or double knock-out cells to examine effects on Notch cell-surface expression. In addition, we used in vitro EGF stability assays to evaluate whether addition of O-glucose or O-fucose stabilizes EGF repeats similar to how O-fucose stabilizes TSRs. Finally, we solved the structure of an EGF repeat with a full O-glucose trisaccharide structure to reveal how the glycans interact with the underlying protein to offer a structural basis for the stabilizing effects of the glycan.
Results

POFUT1 and POGLUT1 facilitate cell surface expression of Notch1 in an additive manner
To examine the effects of loss of O-fucose and O-glucose glycans on Notch1 functions, we genetically deleted POFUT1 or POGLUT1, which are solely responsible for the initial attachment of O-fucose or O-glucose to EGF repeats, respectively, in HEK293T cells. We previously reported that Notch1 is endogenously expressed on the cell surface of HEK293T cells, and that Notch1 produced in HEK293T cells is modified with O-fucose and O-glucose glycans at high stoichiometries at many EGF repeats (Fig. 1A) (13, 14) . Successful bi-allelic mutations at the expected regions in POFUT1 or POGLUT1 were confirmed by genomic DNA sequencing (supplemental Fig. S1A ). As expected, POFUT1 KO cells (clone KB8) or POGLUT1 KO cells (clone OD3) did not show any residual enzymatic POFUT1 or POGLUT1 activities, respectively, in in vitro assay with cell extracts (supplemental Fig. S1B ). Flow cytometric analysis showed that the levels of endogenous Notch1 on the cell surface were reduced by a factor of 2 in either POFUT1 or POGLUT1 KO cells compared with the control wild-type cells (Fig. 1B) . Western blot analysis showed that these single KO cells contained slightly higher levels of full-length Notch1 proteins than that of the wild-type cells (Fig. 1C) . Because full-length Notch1 has not been processed by furin in the Golgi, this observation suggests an increased level of Notch1 in the ER in these cells. These results demonstrated that POFUT1 and POGLUT1 are required for efficient Notch1 trafficking from the ER to the cell surface in HEK293T cells.
We next generated POFUT1 and POGLUT1 double KO cells using the above POFUT1 single KO cells. We confirmed their genotypes by genomic sequencing (supplemental Fig. S1A ) and in vitro enzymatic assays (supplemental Fig. S1B ). Double KO cells showed further reduction in the cell-surface expression of Notch1 compared with POFUT1 or POGLUT1 single KO cells (Fig. 1B) . Of note, Western blot analysis showed increased fulllength Notch1 proteins in the double KO cell lysates compared with the single KO cells (Fig. 1C) . These results strongly suggested that both O-fucose and O-glucose glycans are required for proper Notch1 trafficking in HEK293T cells and that they function in a non-redundant, additive manner.
To demonstrate that the requirement for POFUT1 and POGLUT1 localizes to the EGF repeats in the extracellular domain of Notch1, we performed cell-based secretion assays with a Notch1 construct encoding EGF(1-36) (N1(1-36)) (Fig.  1D ). N1(1-36) was expressed at comparable levels in cell lysates of all cells except the empty vector controls. In wild-type control cells, N1(1-36) was secreted to the culture media. In POFUT1 or POGLUT1 single KO cells, N1(1-36) was not secreted, whereas a control protein without EGF repeats, IgG, was unaffected. In POFUT1 KO cells, co-transfection of POFUT1 rescued this secretion defect, whereas co-transfection of POGLUT1 did not. Likewise, in POGLUT1 KO cells, cotransfection of POGLUT1 rescued the secretion defect, whereas co-transfection of POFUT1 did not. These results support the above notion that addition of O-fucose by POFUT1 and O-glucose by POGLUT1 to the EGF repeats in the Notch1 extracellular domain are both required for efficient protein folding and secretion in HEK293T cells.
O-Fucose and O-glucose stabilize EGF repeats independently
Our recent studies suggested that POFUT2 is required for secretion of TSR-containing proteins because addition of O-fucose stabilizes the folded TSRs in the ER (3). To evaluate whether O-fucose and O-glucose perform a similar function on EGF repeats, we adapted the unfolding assay used in the TSR study to measure the effects of the sugars on the stability of EGF repeats. We used the first EGF repeat from human coagulation factor 9 (hFA9) as a model because it contains similar numbers of amino acids as Notch EGF repeats, contains consensus sequences for both O-fucose and O-glucose modifications, and O-Glycans modulate EGF protein stability is endogenously modified with these types of O-glycans (32) . As with TSRs, folded and denatured hFA9 EGF can be separated by reverse-phase HPLC, and monitoring UV absorbance allows us to quantitate the amounts of each species (supplemental Fig.  S2 ). Dithiothreitol (DTT) unfolded hFA9 EGF by reducing the disulfide bonds, although it was not unfolded in the presence of guanidine hydrochloride (GdnHCl) alone (supplemental Fig.  S2, A and C) . GdnHCl accelerated the rate of unfolding by DTT (supplemental Fig. S2B ). We also compared DTT sensitivities of several EGF repeats from hFA9 and mouse Notch1 (33) (supplemental Fig. S3 ). These EGF repeats showed differential sensitivities to DTT at a specific time point, suggesting different EGF repeats have distinct stabilities. Nonetheless, these results clearly indicated that this assay can be used to monitor the stability of EGF repeats in the presence of DTT.
To examine the effect of O-fucose and O-glucose modifications on the stability of EGF repeats, we modified hFA9 EGF with O-fucose and/or O-glucose glycans by in vitro glycosylation. Successful addition of O-glycans to the EGF repeat was confirmed by mass spectrometry (supplemental Table S1 ). The resulting glycosylated and unglycosylated EGF repeats were subjected to unfolding assays ( Fig 
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not shown), suggesting that the glucose attached covalently to the Ser in the O-glucose consensus stabilizes the folded EGF. We also examined whether elongation of O-glucose by xylose residues affects stability of EGF repeats ( Fig. 2A, top row) . Interestingly, addition of the first xylose canceled the stabilizing effect of O-glucose monosaccharide (i.e. it destabilized the EGF repeat). Addition of the second xylose stabilized the folding of EGF somewhat compared with Xyl-Glc-EGF.
Next, we examined how the addition of O-fucose affected the stability of the hFA9 EGF repeat ( Fig. 2A, bottom row) . Addition of O-fucose also slowed the unfolding of the EGF repeat compared with that of the unglycosylated hFA9 EGF repeat. Addition of both O-fucose and O-glucose unfolded more slowly than either alone, indicating that O-fucose and O-glucose monosaccharides stabilize single EGF repeats in an additive manner. Addition of xyloses to the O-fucose/O-glucose-modified EGF had similar effects to that seen for the O-glucose alone.
hFA9 EGF repeat has a calcium-binding motif (34) , and binding of a calcium ion stabilizes EGF repeats (35) . We confirmed the stabilizing effect of calcium using our unfolding assay (compare Fig. 2B with 2A). We examined whether O-fucose or O-glucose glycans can further stabilize the hFA9 EGF repeat that has been stabilized by calcium. All EGF repeats in the presence of calcium unfolded more slowly than those in the absence of calcium (Fig. 2B compared with 2A) . The O-glycan modifications showed similar effects on unfolding of hFA9 EGF repeat in the absence and presence of calcium ions ( Fig. 2B compared  with 2A) .
Significance of the O-glucose monosaccharide at EGF28 on mouse Notch1 function
We previously reported that O-glucosylation at EGF28 is required for Delta-like 1-induced Notch1 signaling in NIH3T3 cell-based assays (14) . In vitro enzymatic assays suggested that EGF28 of mouse Notch1 is a poorer substrate for POGLUT1, suggesting the efficiency of modification on EGF28 could vary depending on the levels of POGLUT1 in a particular cell (33) . Our mass spectral approach revealed that the vast majority of O-glucose glycans attached to EGF28 of mouse Notch1 from NIH3T3 cells was a monosaccharide species ( Fig. 3A and supplemental Fig. S6 ). These data indicated that the attachment of an O-glucose monosaccharide to mouse Notch1 EGF28 is important for its Delta-like 1-mediated activation.
We then examined whether addition of O-glucose glycans to EGF28 of mouse Notch1 changes protein stability. Because EGF28 of mouse Notch1 does not have a calcium-binding motif, we performed a single time point unfolding assay in the absence of calcium. Because EGF28 was more resistant to DTT than hFA9 EGF repeat (supplemental Fig. S3 ), we optimized DTT concentration so that we could analyze the effects of 
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O-glucose glycan modification (supplemental Fig. S7 ). EGF28 modified with an O-glucose monosaccharide was denatured more slowly than unglycosylated EGF28 (Fig. 3, B and C) . As seen with hFA9 EGF repeat (Fig. 2) , the first xylose destabilized EGF28, whereas the second xylose stabilized EGF28 (Fig. 3, B  and C) . Thus, O-glucose monosaccharides specifically at EGF28 may regulate Notch1 activation through modulating the stability of the EGF repeat.
Structural analysis of hFA9 EGF repeat modified with Oglucose glycans
To gain insight into the structural effects of O-glucose glycans on EGF repeats, we crystallized the hFA9 EGF repeat modified with O-glucose trisaccharide and determined its crystal structure to 2.2 Å resolution (Fig. 4 and supplemental Table S2 ). We found that the elongated O-glucose glycan occupied and filled up a deep surface groove of the EGF, and there were numerous intramolecular interactions between the glycan and EGF repeat (Fig. 4A) . The O-glucose of the trisaccharide stacked against proline 55 and interacted with the main chain atoms of glutamine 50. The first xylose residue of the trisaccharide stacked against tyrosine 69 and formed the hydrogen bond with the main chain oxygen atom of asparagine 67. The second xylose stacked against tyrosine 69 and the side chains of serine 68 and lysine 80. This xylose further formed a H-bond with the main chain nitrogen atom of tyrosine 69. Proline 55 and tyrosine 69 formed a hydrophobic patch, which we previously identified as a structural signature for O-glucose addition by Rumi/ POGLUT1 (36). Here we found this patch forms van der Waals interaction with all three sugar rings of the trisaccharide (Fig. 4,  B and C) . Sequence analysis of mouse Notch1 receptor showed that the hydrophobic patch is conserved in 15 of the 17 EGF repeats with O-glucose modifications (14) ; proline 55 in EGF9 and tyrosine 69 in EGF10 are each replaced by an alanine (Fig. 4D) . Interestingly, the structure of trisaccharide-modified hFA9 is similar to its unmodified counterpart (PDB code 1EDM), with an r.m.s.d. of only 0.48 Å, indicating that there was no significant conformational change upon attachment of the O-glucose trisaccharide (Fig. 5A) . Because the interaction between O-glucose trisaccharide and hFA9 involves either conserved residues such as proline 55 and tyrosine 69 or main chain atoms of non-conserved residues, we suggest that the mode of interaction observed here is likely applicable to many other EGF repeats with very different primary sequences such as those in mouse or human Notch receptors. Indeed, we observed similar stabilizing effects of O-glucose glycans on FA9 EGF repeat and mouse Notch1 EGF28 (Figs. 2 and 3) .
Previous studies have revealed structures of EGF modified by O-fucose and O-glucose glycans (37) (38) (39) . We superimposed the current structure of trisaccharide-modified hFA9 with an O-glucose monosaccharide-modified or an O-glucose disaccharide-modified EGF12, and we found that they align well with an r.m.s.d. of 0.83 and 0.65 Å, respectively (Fig. 5A) . It is clear that O-glucose saccharides, mono-, di-, or tri-saccharide, all fold back onto the surface groove of the EGF, rather than protruding to the solvent. The trisaccharide forms a larger interface with underlying surface groove than that of the monoand disaccharide (Fig. 5, A-D) . We further compared the above-described structures with the structure of EGF12 either unmodified or modified with an O-fucose monosaccharide or an O-fucose disaccharide (Fig. 5, A and E-G) (40) , and we found that O-fucose glycans are on the opposite side of the protein from where the O-glucose glycans attach. This result supports our cell biological and biochemical observation that the effects of O-fucose and O-glucose on EGF repeats are independent and therefore additive.
Discussion
In this study, we showed that POFUT1 and POGLUT1 function in an additive, non-redundant manner for efficient cellsurface expression of endogenous Notch1 and secretion of the 
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Notch1 extracellular domain in HEK293T cells. We also showed that simple addition of O-fucose and O-glucose glycans stabilizes a single EGF repeat in an additive, non-redundant manner as measured using in vitro unfolding assays. Taken together, these data suggest that POFUT1 and POGLUT1 participate in a novel ER quality control pathway for the folding and stabilization of EGF repeats similar to what we have previously shown for POFUT2 and TSRs (3). In addition, our structural analysis of the hFA9 EGF repeat modified with an O-glucose trisaccharide by X-ray crystallography indicated that the O-glucose trisaccharide lies flat on the surface of the EGF repeat and is highly ordered, associating with underlying amino acids, providing a rationale for the observed stabilization of the EGF repeat.
Our results are consistent with the cooperative effects of POFUT1 and POGLUT1 on Notch trafficking recently reported in the fly system (31) . Addition of xylose to O-glucose has been reported to reduce the level of cell-surface Notch in Drosophila (25) . Analysis of Drosophila Notch produced in S2 cells suggests that the majority of O-glucose glycans are the Xyl-Glc disaccharide with very little trisaccharide (12) . Thus, the effect of xylose on cell-surface expression is consistent with our result that addition of a single xylose to O-glucose destabilizes EGF repeats (Fig. 2, A and B) . A more recent report from the Matsuno and co-workers (41) suggested that addition of xylose to O-glucose was partially redundant with O-fucose in Notch trafficking and function, inconsistent with our stabilization data. A potential explanation for this difference was also presented in this report, that addition of xylose to O-glucose mainly affects transcytosis of Notch from the apical plasma membrane to the adherens junctions, thereby also affecting cell-surface levels of Notch (41) . Although it is likely that the destabilization caused by addition of xylose to O-glucose mainly affects trafficking to the plasma membrane, it is possible that destabilization also affects the conformation of Notch, which may be important for transcytosis. Alternatively, xylose may affect transcytosis independently of destabilization. A recent study also demonstrated that xylosylation of the O-glucose glycans of Drosophila Notch decreased trans-but not cisDelta ligand binding (26) . Further work on xylosylation is clearly needed to better understand its effects on Notch. Thus, many of the Notch trafficking defects observed in the fly O-Glycans modulate EGF protein stability mutants may be explained by loss of stabilizing effects of these glycans on EGF repeats. The cooperative/additive effect of adding glycans to EGF repeats on stabilization also suggests that there are multiple mechanisms to efficiently stabilize and fold an EGF repeat. Thus, the differences in Notch trafficking seen in distinct systems lacking either POFUT1 or POGLUT1 (28 -30) could well be attributed to differences in levels of these enzymes or other chaperones/quality control systems for EGF folding in each distinct cell system.
Our structural data suggest that the mechanism for EGF stabilization by glycans is the multiple interactions with underlying amino acids. Significantly, addition of the O-glucose trisaccharide did not alter the conformation of the EGF repeat. We had previously shown that addition of O-fucose monosaccharide or disaccharide to EGF12 of Notch1 also does not induce conformational change of the EGF repeat, but similar to what we observed here, the O-fucose glycan has multiple interactions with underlying amino acids (40) . Similar results have been reported by other investigators (37, 39) . These glycans are highly ordered on the surface of EGF repeats and seem to be "born to stabilize" EGF repeats. Because EGF repeats share a unique structural fold, modulations of EGF stability by O-glycans revealed in this study are likely important for Notch and other targets of POFUT1 and POGLUT1. Highly ordered O-linked sugar modifications may also be important for molecular recognition because O-linked sugars may work as "surrogate amino acids" in a given protein structure. For example, O-fucose glycans attached to EGF8 and EGF12 of Notch1 interact with the underlying amino acids and form a part of the Notch ligand-binding surface (37) (38) (39) (40) . O-Glucose glycans on Notch are not required for Notch-ligand binding (8, 16) , which is supported by recent co-crystallized structures of Notch1 with ligands (37, 38) . Instead, O-glucose glycans apparently conceal the exposed hydrophobic region of EGF repeats that may otherwise non-specifically bind to unrelated molecules or Notch itself (Fig. 4) . Indeed, the accumulation of Notch in POGLUT1-null HEK293T cells may be partly attributed to aggregation of Notch1 via hydrophobic interactions. Of note, our recent structural analysis of POGLUT1 indicated that the hydrophobic region formed by tyrosine 69 and proline 55 of hFA9 EGF repeat is specifically recognized by POGLUT1/Rumi (36).
It is not yet clear why there are so many EGF repeats in the Notch extracellular domain, and why O-linked glycan modifications are so conserved. In the Notch receptor activation cascade, ligand binding to Notch followed by ligand endocytosis into signal-sending cells generates a pulling force that is required for Notch receptor activation in signal-receiving cells (42) . Alterations in the rigidity of individual EGF repeats may play an important role in regulation of generation of mechanical force necessary for Notch activation. Our data suggest the alterations in O-glycosylation of EGF repeats may provide a mechanism to regulate the rigidity of the Notch extracellular domain.
Experimental procedures
CRISPR/Cas9-mediated genome editing
HEK293T cells (ATCC) were grown in DMEM-high glucose supplemented with 10% bovine calf serum and 1% penicillin and streptomycin. Gene-specific gRNAs were inserted into CAG-Cas9 -2A-GFP vector (43) . The gRNA sequence for targeting POFUT1 exon 1 was 5Ј-CAGTAGAGCAGGTAACCG-GC-3Ј. The sequence for targeting POGLUT1 exon 1 was 5Ј-GGTGGGCTAGCTCGCCGCTT-3Ј. The expression vector (2 g) was transfected in HEK293T cells grown in 10-cm dishes using PEI. Single cell sorting was performed in 96-well plates using the MoFlo XDP Cell Sorter (Beckman Coulter) at the Center for Tropical and Emerging Global Diseases Cytometry Resource Laboratory at the University of Georgia. Successful gene editing was confirmed by genomic PCR with Q5 polymerase (New England Biolabs) and DNA sequencing. For establishing double knock-out cells, POGLUT1 KO cells (clone OD3) were transfected with CAG-Cas9 -2A-GFP vector encoding the gRNA targeting POFUT1 exon 1. After a 24-h transfection, GFP-positive cells were sorted in 96-well plates. Successful gene editing was confirmed by genomic PCR with Q5 polymerase and DNA sequencing.
Analysis of endogenous Notch1 expression by flow cytometry and Western blotting
Notch1 cell-surface expression in HEK293T cells was analyzed using an Accuri6 flow cytometer (BD Biosciences). HEK293T cells (wild-type, POFUT1 null, POGLUT1 null, or double null) were washed with Hanks' balanced salt solution supplemented with 1% BSA, 1 mM CaCl 2 , and 0.02% NaN 3 (FACS buffer) and then incubated with 16 g/ml phycoeryth- 
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rin-conjugated anti-human Notch1 (BioLegend, clone MHN1-519) or phycoerythrin-conjugated mouse IgG1 (BioLegend, clone MOPC-21) as control on ice for 1 h. After washing with 1 ml of FACS buffer twice, the cells were analyzed by flow cytometry. Endogenous Notch1 proteins in the whole-cell lysates were analyzed by Western blotting. Cell lysates were prepared with RIPA buffer containing protease inhibitors. Protein concentrations in cell lysates were determined by using the protein assay kit (Thermo Fisher Scientific) with BSA as a standard. Twenty g of total proteins were loaded onto 10% SDS-PAGE, transferred to nitrocellulose membrane, and blocked with 5% milk in TBS containing 0.1% Tween 20 (TBS-T) at room temperature for 1 h. The membrane was incubated with rabbit antiNotch1 antibody (Cell Signaling Technology, clone D1E11, 1:2,000) or mouse anti-tubulin antibody (Sigma, clone DM1A, 1:2,000) at 4°C overnight. After washing with TBS-T three times for 10 min, the membrane was incubated with IRDye 800-conjugated goat anti-rabbit antibody (LI-COR 1:10,000) or IRDye 680-conjugated goat anti-mouse IgG antibody (LI-COR, 1:10,000) at room temperature for 1 h. After the membrane was washed with TBS-T for 10 min six times, and the bands were visualized using an Odyssey System (LI-COR).
Secretion assays with Notch1 extracellular domain
The plasmids used for secretion assays were pSecTag2c-Notch1 EGF(1-36)-Myc-His 6 (44), pcDNA4-POGLUT1-Myc-His 6 (45) , and pSecTag2c-POFUT1-Myc-His 6 (7) . A plasmid encoding human IgG (3) was used as secretion control. HEK293T cells (1 ϫ 10 6 ) were seeded in 6-well dishes in DMEM, 10% calf serum and transiently transfected with 1 g/well pSecTag-Notch1 EGF(1-36)-Myc-His 6 (or empty vector), 0.5 g/well plasmids for POGLUT1 or POFUT1 (or corresponding empty vector), and 0.5 g/well IgG plasmid using PEI. After 4 -5 h, the medium was changed to 1 ml of Opti-MEM I. The cells were cultured for another 3 days. Culture media samples were collected, and cell pellets were lysed as described above. Samples were loaded onto 10% SDS-PAGE, transferred to nitrocellulose membrane, and blocked with 5% milk in TBS containing 0.1% Tween 20 (TBS-T) at room temperature for 1 h. The membrane was incubated with anti-Myc antibody (9E10) diluted in 5% milk in TBS-T at 4°C overnight. After washing with TBS-T for 10 min three times, the membrane was incubated with IRDye 680-conjugated goat antimouse IgG antibody (LI-COR 1:10,000) and IRDye 800-conjugated goat anti-human IgG antibody (LI-COR, 1:10,000) diluted in TBS-T at room temperature for 1 h. After the membrane was washed with TBS-T for 10 min six times, the bands were visualized using an Odyssey System (LI-COR).
Preparation of EGF repeats and glycosyltransferases
EGF repeats were expressed in Escherichia coli and purified as described previously (33) . The cDNA encoding EGF1 of human factor IX and EGF28 of mouse Notch1 was cloned into a pET20b(ϩ) expression vector. BL21 (DE3) E. coli was transformed with the expression vectors. Protein expression was induced with 0.4 mM isopropyl 1-thio-␤-D-galactopyranoside at the time when the A 600 values of the E. coli cell suspensions reached 0.5-0.6, and the E. coli were cultured in the shaker at 200 rpm at 20°C overnight. The E. coli pellet was suspended in 50 mM Tris-HCl, pH 8.0, with 200 mM PMSF and sonicated. After centrifuging, the soluble fractions were applied to Ni-NTA-agarose (Qiagen) affinity chromatography, and after washing, the bound proteins were eluted with TBS containing 250 mM imidazole. Further purification of the EGF repeat was performed by reverse phase HPLC (1200 Series, Agilent Technologies). A preparatory C18 reverse phase column (Protein and Peptide C18, 10 ϫ 250 mm, Vydac) was eluted with a linear gradient from 10 to 90% solvent B (0.1% TFA in 80% acetonitrile in water) in solvent A (0.1% TFA in water) at a flow rate of 2 ml/min for 60 min. Eluates were monitored for absorbance at 214 nm.
Recombinant glycosyltransferases (POGLUT1-MycHis 6 , GXYLT1-MycHis 6 , XXYLT1-MycHis 6 , and His 6 -POFUT1) were expressed in HEK293T cells and purified from medium by Ni-NTA-agarose (Qiagen) affinity chromatography as described previously (33) . Enzyme concentrations were determined by 10% SDS-PAGE followed by Coomassie staining with BSA as a standard.
Preparation of glycosylated EGF repeats
In vitro glycosylation and purification of glycosylated EGF repeats were performed as described previously (33) . 
Mass spectrometry
EGF repeats were injected to Q-Exactive Orbitrap mass spectrometer (Thermo Fisher Scientific) equipped with an Easy nano-LC 1000 HPLC system with Accucore C4 reverse phase column (Thermo Fisher Scientific). Separation was performed with a binary gradient solvent system that consists of solvent A (0.1% formic acid in water) and solvent B (80% acetonitrile and 0.1% formic acid in water) with a constant flow rate of 300 nl/min. Spectra were recorded with a resolution of 70,000 in the positive polarity mode over the range of m/z 400 -2,000 and an automatic gain control target value was 1 ϫ 10 6 . Raw data files were analyzed using Proteome Discoverer version 2.1 (Thermo Fisher Scientific).
Mass spectral analysis of mouse Notch1 produced in NIH3T3 cells was performed as described previously (13) . NIH3T3 cells were transiently transfected with pSecTag2c-Notch1 EGF(1-36)-Myc-His 6 and purified from the medium using Ni-NTA-agarose (Qiagen) affinity chromatography. Purified mouse Notch1 EGF(1-36)-Myc-His 6 was in-gel digested by chymotrypsin. Chymotryptic digests were analyzed O-Glycans modulate EGF protein stability by nano-LC-MS/MS using an Agilent 6130 mass spectrometer as described (13) . Extracted ion chromatograms (EICs) were performed by searching for the ions corresponding to the doubly and triply charged glycoforms of the peptide, 1063 CDSAP-CKNGGRCW 1075 , from EGF28 of mouse Notch1. The predicted m/z for the doubly charged ions corresponding to the unglycosylated, O-glucose monosaccharide, disaccharide, or trisaccharide glycoforms used for EIC searches were 784.9, 865.9, 931.9, or 997.9, respectively.
Unfolding assay
HPLC-based unfolding assays were performed essentially as described (3) . EGF proteins (5-10 M) were denatured in 100 mM Tris-HCl, pH 7.4, containing 0.6 M GdnHCl, 2 mM dithiothreitol (DTT), and 10 mM EDTA at room temperature for various times. The unfolding reaction was stopped by addition of 2% (v/v) trifluoroacetic acid (TFA). The samples were analyzed by reverse phase HPLC, and the absorbance at 214 nm wavelength was monitored. Quantification of areas under the curve was performed by using Agilent software.
X-ray crystallography
Lyophilized hFA9 EGF repeat with O-glucose trisaccharide modification was solubilized to 20 mg/ml in 10 mM HEPES and 10 mM CaCl 2 . Hanging-drop diffusion method was used to produce initial cluster crystals in mother liquor containing 0.1 M Tris, pH 8.5, 15% glycerol, and 1.6 M (NH 4 ) 2 SO 4 at 20°C. Single crystals with good diffraction quality were obtained by seeding optimization with 5% 2,2,2-trifluoroethanol as additive. Well solution with increasing glycerol concentrations up to 30% was used as the cryo-protectant for flash-freezing crystals in liquid nitrogen. X-ray diffraction data were collected at the APS LRL-CAT at 0.9793-Å wavelength. Diffraction images were processed and scaled in XDS (46) and Mosflm (47) . The structure was solved by molecular replacement with MOLREP (48) using hFA9 EGF structure (PDB code 1EDM) as the search model, followed by one round of automatic refinement in REFMAC (49) in CCP4 suite (50) . O-Glucose trisaccharide was modeled based on the well-defined density present at this stage. Then, several additional rounds of refinement were carried out in REFMAC followed by manual adjustment in COOT (51) . Water molecules were added at the last step of refinement. The crystallographic statistics for data collection and refinement are presented in supplemental Table S2 .
Accession codes
The coordinate and the structure factor files of hFA9-Glc-Xyl-Xyl were deposited in PDB with accession number 5VYG. 
